Abstract: A process for dietary calcium supplementation. Oral dosage of a composition comprising calcium citrate is utilized to provide an efficiently absorbable chemical form of calcium, while raising urinary level of citrate. Because of improved absorption of calcium, osteoporosis development is precluded. Since citrate retards precipitation of stone-forming calcium stones, the risk of calcium nephrolithiasis (resulting from calcium supplementation) is reduced.
Abstract: A method for protecting synthetic and natural fibres against phototendering. The method comprises treating the fibres with a substituted benzotriazolesulfonate of the following formula: ##STR1## wherein (I) R.sub.1 is hydrogen or halogen, R.sub.2 is hydrogen or alkyl, R.sub.3 is hydrogen or hydroxy, R.sub.4 is --SO.sub.3 X where X is hydrogen or an alkali metal, and R.sub.5 is hydrogen, with the proviso that R.sub.2 is not methyl when R.sub.1 and R.sub.3 are hydrogen; or(II) R.sub.1, R.sub.3 and R.sub.4 are hydrogen, R.sub.2 is --SO.sub.3 X where X is hydrogen or an alkali metal, and R.sub.5 is --OR.sub.6 where R.sub.6 is hydrogen or alkyl; or(III) R.sub.1 is hydrogen or halogen, R.sub.2 is --SO.sub.3 X where X is hydrogen or an alkali metal, R.sub.3 and R.sub.5 are hydrogen, and R.sub.4 is hydrogen, alkyl or benzyl; or(IV) R.sub.1 is --SO.sub.3 X where X is hydrogen or an alkali metal, R.sub.2 is alkyl, R.sub.3 and R.sub.5 are hydrogen, and R.sub.4 is hydrogen or alkyl;under acidic conditions.
Type:
Grant
Filed:
March 17, 1987
Date of Patent:
September 13, 1988
Assignee:
Board of Regents, U T Systems
Inventors:
Neil A. Evans, Ian H. Leaver, Judi Rosevear, Peter J. Waters, John F. K. Wilshire